Lombard Odier Asset Management (USA)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,358
Closed -$305K 253
2026
Q1
$305K Buy
+1,358
New +$338K 0.03% 186
2025
Q4
Sell
-1,271
Closed -$348K 394
2025
Q3
$348K Buy
1,271
+297
+30% +$81.1K 0.02% 337
2025
Q2
$251K Buy
+974
New +$232K 0.02% 331
2016
Q4
Sell
-15,700
Closed -$1.02M 233
2016
Q3
$1.02M Buy
+15,700
New +$1.05M 0.09% 193

Other funds holding RMD

Lombard Odier Asset Management (USA)'s RMD Position: Q2 2026 in Review

Lombard Odier Asset Management (USA) sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,358 shares — an estimated $305K sold.

Lombard Odier Asset Management (USA) first reported a position in RMD in Q3 2016 and held it in 4 quarters. The position peaked at $1.02M in Q3 2016. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Lombard Odier Asset Management (USA) reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 1,358 ResMed shares in Q2 2026, an estimated $305K.
  • Lombard Odier Asset Management (USA) first reported a position in ResMed in Q3 2016 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s ResMed position peaked at $1.02M in Q3 2016.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2026, filed 14 Aug 2026.